Most used, strongest evidence
Go/No-Go Task
Measures response inhibition by requiring participants to respond to 'go' stimuli and withhold responses to 'no-go' stimuli.
4 to 5 minutes · Desktop or laptop
AEvidence3,039 papers, up 7%
Response inhibition tests you can run online
Response inhibition tests measure how well people stop or hold back a response.
Response inhibition tests
4 tests
Stop-Signal Task
Measures action cancellation by asking participants to make speeded left/right responses and withhold the response when a stop signal appears.
5 to 7 minutes · Desktop or laptop
BEvidence897 papers, about the sameAntisaccade Task
Measures the ability to stop a reflexive glance toward a sudden cue. A small square flashes on one side, then a brief arrow appears and is covered. In the antisaccade block the arrow appears on the opposite side, so participants must look away from the cue at once to read it. They answer with the arrow keys.
10 to 12 minutes · Desktop or laptop
AEvidence557 papers, down 8%Affective Go/No-Go
Measures affective response inhibition by asking participants to respond to words from one emotional valence while withholding responses to the other.
5 to 6 minutes · Desktop or laptop
CEvidence123 papers, down 20%
How often researchers use them
Papers that name each test, counted for our test census. Tests counted together share a bar. Counts and grades describe the published research on each task, not ConductCognition's version of it.
- Go/No-Go Task3,039 papers
- Stop-Signal Task897 papers
- Antisaccade Task557 papers
- Affective Go/No-Go123 papers
Source: ConductCognition test census 0.14.0, counted 31 October 2026 from OpenAlex and ClinicalTrials.gov.
Show the numbers
| Test | Papers, 2021 to 2025 | Compared with 2016 to 2020 | Use grade | Evidence grade |
|---|---|---|---|---|
| Go/No-Go Task | 3,039 | Up 7% | A | A |
| Stop-Signal Task | 897 | About the same | B | B |
| Antisaccade Task | 557 | Down 8% | B | A |
| Affective Go/No-Go | 123 | Down 20% | C | C |
What the grades mean
- Use grade
- A: 1,000 or more papers from 2021 to 2025
- B: 300 to 999 papers from 2021 to 2025
- C: 100 to 299 papers from 2021 to 2025
- D: 30 to 99 papers from 2021 to 2025
- E: fewer than 30 papers from 2021 to 2025
- Evidence grade
- A: at least 25 papers report its test-retest reliability and at least 25 registered clinical studies use it as an outcome
- B: at least 8 test-retest papers, and either 5 registered clinical studies or 150 reliability or validity papers
- C: at least 2 test-retest papers, 30 reliability or validity papers or 3 registered clinical studies
- D: little published measurement evidence found
Build a study from these tests
Pick tests from any domain and preview them before you invite anyone.